ShephardRMWhiteHAShirkeyAL. Anticoagulant prophylaxis of thromboembolism in post-surgical patients. Am J Surg1966; 112: 698–702.
3.
International Multicentre Trial.Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet1975; ii: 45–51.
4.
CoventryMBNolanDRBeckenbaughRD. ‘Delayed’ prophylactic anticoagulation: A study of results and complications in 2012 total hip arthroplasties. J Bone Joint Surg [Am]1973; 55: 1487–92.
5.
EskelandGSolheimKSkhortenF.Anticoagulant prophylaxis, thromboembolism and morality in elderly patients with hip fracture: A controlled clinical trial. Acta Chir Scand1986; 131: 16–29.
6.
ClagettGPReischJS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg1988; 208: 227–40.
7.
CollinsRScrimgeourAYusefSReduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med1988; 318: 1162–73.
8.
ColditzGATudenRLOsterG.Rates of venous thrombosis after general surgery: Combined results of randomized clinical trials. Lancet1986; 19: 143–46.
9.
NicolaidesANArcelusJBelcaroGPrevention of venous thromboembolism. Int Angiol1992; 11: (3): 151–161.
10.
KakkarVStamatakisJDBentleyPGProphylaxis for post-operative deep-vein thrombosis. JAMA1979; 241: 39–42.
11.
AndersonFAWheelerHBGoldbergRJPhysician practices in the prevention of venous thromboembolism. Ann Intern Med1991; 115: 581–85.
12.
BergqvistD.Prevention of postoperative deep vein thrombosis in Sweden: Results of a survey. World J Surg1980; 4: 489–95.
13.
LaverickMDCroakSAMollanRA. Orthopedic surgeons and thromboprophylaxis. Br Med J1991; 303: 549–50.
14.
SalzmanEWDaviesGC. Prophylaxis of venous thromboembolism. Analysis of cost-effectiveness. Ann Surg1980; 191: 207.
15.
HullRHirshJSackettDLCost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can Med Assoc J1982; 127: 990–92.
16.
OsterGTudenRLColditzGA. A cost-effectiveness analysis of prophylaxis against deep vein thrombosis in major orthopedic surgery. JAMA1987; 257: 203–208.
17.
BergqvistDMatzschTJendtegSThe cost-effectiveness of prevention of post-operative thromboembolism. Acta Chir ScandSuppl1990; 556: 36–41.
18.
HauchOKyattarSCJorensenLN. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery. Semin Thromb Hemost1991; 17: (suppl 3): 280–83.
19.
LeyvrazPFRichardJBachmannFAdjusted versus fixed dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med1983; 309: 954–58.
20.
LeyvrazPFBachmannFHoekJPrevention of deep vein thrombosis after hip replacement: Randomised comparison between unfractionated heparin and low molecular weight heparin. Br Med J1991; 303: 543–48.
21.
KakkarVVCohenATEdmonsonRALow molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet1993; 341: 259–65.
22.
KakkarVVMurrayWJG. Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thromboembolism: A cooperative study. Br J Surg1985; 72: 786–91.
23.
BergqvistDMatzschTBrumarkULow-molecular-weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. Br J Surg1988; 75: 888–91.
24.
FrickerJPVergnesYSchachRLow dose heparin versus low molecular weight heparin Kabi 2165 in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest1988; 18: 561.
25.
SamamaMBernardPBonnardotJPLow-molecular-weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. Br J Surg1988; 75: 128–31.
26.
The European Fraxiparin Study Group.Comparison of a low-molecular-weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg1988; 75: 1058–63.
27.
CaenJP. A randomized double-blind study between a low-molecular-weight heparin Kabl 2165 and standard heparin in the prevention of deep-vein thrombosis in general surgery. A French multicentre trial. Thromb Haemost1988; 59: 216–20.
28.
LeizoroviczAPicoletHPeyrieuxJCPrevention of perioperative deep vein thrombosis in general surgery: A multicentre double-blind study comparing two doses of logiparin and standard heparin. Br J Surg1991; 78: 412.
29.
BoneuB.An international multicentre study: Clivarin(R) in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin(R) Assessment Group. Blood Coagulat Fibrinol1993; 4 (suppl 1): S21–S22.
30.
GallusACadeJOckelfordPOrgaran (Org 10172) or heparin for preventing venous thromboembolism after elective surgery for malignant disease? A double-blind, randomised multicentre comparison. Thromb Haemost1993; 70: 562–67.
31.
DechavanneMVilleDBerruyerMRandomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery. Haemostasis1989; 1: 5–12.
32.
TurpieAGLevineMNHirshJA randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med1986; 315: 925–29.
33.
PlanesAVochelleNMazasFPrevention of postoperative venous thrombosis: A randomized trial comparing unfractionated heparin with low-molecular-weight heparin in patients undergoing total hip replacement. Thromb Haemost1988; 60: 407–10.
34.
LevineMNHirshJGentMPrevention of deep vein thrombosis after elective hip surgery: A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med1991; 114: 545–51.
35.
ErikssonBIKäleboPAnthmyrBAPrevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg [Am]1991; 73-A: 484–93.
36.
The Danish Enoxaparin Study Group.Low-molecular weight heparin (Enoxaparin) vs Dextran 70. Arch Intern Med1991; 151: 1621–24.
37.
TørholmCBroengLJørgensenPSThromboprophylaxis by low-molecular-weight heparin in elective hip surgery: A placebo controlled study. J Bone Joint Surg [Br]1991; 73-B: 434–38.
38.
LassenMRBorrisLCChristiansenHMPrevention of thromboembolism in 190 hip arthroplasties. Acta Orthop Scand1991; 62: 33–38.
39.
PlanesAVochelleNFagolaMPrevention of deep vein thrombosis after total hip replacement: The effect of low-molecular-weight heparin with spinal and general anesthesia. J Bone Joint Surg [Br]1991; 73-B: 418–22.
40.
LeclercJRGeertsWHDesjardinsLPrevention of deep vein thrombosis after major knee surgery – a randomized, double-blind trial comparing a low-molecular-weight heparin fragment (Enoxaparin) to placebo. Thromb Haemost1992; 67: 417–23.
41.
HullRDRaskobGEPineoGFA comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med1993; 329: 1370–76.
42.
SpiroTEJohnsonGJChristieMJEfficacy and safety of Enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med1994; 121: 81–89.
43.
ColwellCWSpiroTETrowbridgeAAUse of Enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. J Joint Bone Surg [Am]1994; 76-A: 3–14.
44.
HoekJNurmohamedMTten CateHPrevention of deep vein thrombosis following total hip replacement by a low-molecular-weight heparinoid. Thromb HaemostSuppl1989; 62: 1637.
45.
BergqvistDKettunenKFredinHThromboprophylaxis in hip fracture patients – a prospective randomized comparative study between ORG 10172 and dextran. Surgery1991; 109: 617–22.
46.
GerhartTNYettHSRobertsonLKLow-molecular-weight heparinoid compared with warfarin for prophylaxis of deep vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial. J Bone Joint Surg [Am]1991; 73-A: 494–502.
47.
NurmohamedMTRosendaalFRBüllerHRLow molecular weight heparin in the prophylaxis of venous thrombosis: A meta-analysis. Lancet1992; 340: 152–56.
48.
FrancisCWPellegriniVDMarderVJComparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA1992; 267: 2911–15.
49.
PaiementFWessingerSJWaltmanWCLow-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty1987; 2: 23–26.
50.
KaempffeFALifesoRMMeinkingC.Intermittent pneumatic compression versus Coumadin: Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop1991; 269: 89–97.
51.
PowersPJGentMJayRA randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med1989; 149: 771–74.
52.
PollerLMcKernanAThomsonJMFixed minidose warfarin: A new approach to prophylaxis against venous thrombosis after major surgery. Br Med J1987; 285: 1309–12.
53.
BernMMLokichJJWallachSRVery low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med1990; 112: 423–28.
54.
DaleCGallusAWycherleyAPrevention of venous thrombosis with minidose warfarin after joint replacement. Br Med J1991; 303: 224.
55.
RobertsVCSabriSBeelyAHThe effect of intermittently applied external pressure on the hemodynamics of the lower limb in man. Br J Surg1972; 59: 233–36.
56.
TurpieAGGGallusABeattieWSPrevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology1977; 27: 435–38.
57.
TurpieAGDelmoreTHirshJPrevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thromb Res1979; 16: 611–16.
58.
SkillmanJJCollinsRRCoeNPPrevention of deep vein thrombosis in neurosurgical patients: A controlled, randomized trial of external penumatic compression boots. Surgery1978; 83: 354–58.
59.
HullRDRaskobGGentMEffectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA1990; 263: 2313–17.
60.
HullRDDelmoreTJHirshJEffectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res1979; 16: 37–45.
61.
McKennaRGalanteJBachmannFPrevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J1980; 1: 514–17.
62.
SantoriFSVitulloAStopponiMSantoriNGheraS.Prophylaxis against deep-vein thrombosis in total hip replacement. J Bone Joint Surg [Br]1994; 76-B: 579–83.
63.
BradleyJGKrugenerGHJagerHJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J Arthroplasty1993; 8: 57–61.
64.
TurnerGMColeSEBrooksJH. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery. Br J Obstet Gynaecol1984; 91: 588–91.
65.
IshakMAMoreleyKD. Deep venous thrombosis after total hip arthroplasty: A prospective controlled study to determine the prophylactic effect of graded pressure stockings. Br J Surg1991; 68: 429–32.
66.
AllanAWilliamsJTBoltonJPThe use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg1983; 70: 172–74.
67.
WellsPSLensingAWAHirshJ.Graduated compression stockings in the prevention of postoperative venous thromboembolism. Arch Intern Med1994; 154: 67–72.
68.
Antiplatelet Trialists' Collaboration.Collaborative overview of randomized trials of antiplatelet therapy. III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J1994; 308: 235–46.
69.
HyersTMHullRDWegJ.Antithrombotic therapy for venous thromboembolic disease. Chest1991; 102: 408S–425S.
70.
ImperialeTFSperoffT.A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA1994; 271: 1780–85.
71.
LeclercJRGeertsWHDesjardinsLPrevention of venous thromboembolism (VTE) after knee arathroplasty – a randomized double-blind trial, comparing enoxaparin to warfarin sodium [Abstract]. Chest1994; 106: (suppl): 48s.